Craven House Capital PLC Share Price London S.E.
Equities
GB00B01TVW49
Investment Management & Fund Operators
End-of-day quote
Other stock markets
|
||
- GBX | - |
28/02 | EARNINGS: Hutchmed revenue surges, Craven House's loss widens | AN |
28/02 | Craven House Capital Plc Reports Earnings Results for the Half Year Ended November 30, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 657K 54.81M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -5M -417M | EV / Sales 2022 | - |
Net cash position 2022 | 1K 83.45K | Net cash position 2023 | 4K 334K | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.93
x | P/E ratio 2023 |
-0.12
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.73% |
Managers | Title | Age | Since |
---|---|---|---|
Tamra Spink
SEC | Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pajak
CHM | Chairman | 45 | 31/10/31 |
Balbir Bindra
BRD | Director/Board Member | - | 27/11/27 |
Calum Morrison
BRD | Director/Board Member | 55 | 05/16/05 |
1st Jan change | Capi. | |
---|---|---|
+0.48% | 121B | |
+4.75% | 98.23B | |
+14.79% | 67.63B | |
+23.75% | 65.62B | |
+12.97% | 43.97B | |
+15.68% | 43.64B | |
+22.39% | 36.24B | |
+6.86% | 25.7B | |
+0.14% | 23.37B |